According to the research report, the global market for Messenger RNA Vaccines and Therapeutics should grow from US$ 9800 million in 2022 to US$ 24570 million by 2029, with a CAGR of 12.6% for the period of 2023-2029.

China Messenger RNA Vaccines and Therapeutics market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Messenger RNA Vaccines and Therapeutics market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Self-amplifying segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Cancer has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Messenger RNA Vaccines and Therapeutics include BioNTech, Moderna, CureVac, Pfizer, Glaxo Smith Kline's, Daiichi Sankyo Company, Intellia Therapeutics, Arcturus Therapeutics and Emmy Vaccine, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

An mRNA vaccine is a vaccine that uses a molecular copy of messenger RNA to generate an immune response. [1] Such vaccines deliver antigen-coding mRNA molecules into immune cells, which use the designed mRNA as a template to build foreign proteins normally produced by pathogens such as viruses or cancer cells. These protein molecules stimulate an adaptive immune response, teaching the body to recognize and destroy the corresponding pathogen or cancer cell. mRNA is composed of RNA encapsulated in lipid nanoparticles, which protect the RNA strand and facilitate its uptake into cells. Reactogenicity, the propensity of the vaccine to produce adverse reactions, was similar to that of traditional non-RNA vaccines. People prone to autoimmune reactions may experience adverse reactions to messenger RNA vaccines. Compared with traditional vaccines, mRNA vaccines have the advantages of being easy to design, fast in production, low in cost, capable of inducing cellular and humoral immunity, and not interacting with genomic DNA.

This report aims to provide a comprehensive study of the global market for Messenger RNA Vaccines and Therapeutics.
Key Takeaways and Highlights

(1) Global Messenger RNA Vaccines and Therapeutics market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Messenger RNA Vaccines and Therapeutics market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Messenger RNA Vaccines and Therapeutics market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Messenger RNA Vaccines and Therapeutics segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Messenger RNA Vaccines and Therapeutics segment by type and by application and regional segment by type and by application.

(6) Messenger RNA Vaccines and Therapeutics industry supply chain, upstream, midstream and downstream analysis.

Regional Breakdown: Analyzing Market Segments by Geography

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Segmenting by Type: Comprehensive Coverage and Analysis

Self-amplifying

Conventional Non-amplifying

Application-Based Segmentation: Unlocking Market Opportunities

Cancer

Infectious Diseases

Autoimmune Diseases

Others

In the Spotlight: A Closer Look at Market Players

BioNTech

Moderna

CureVac

Pfizer

Glaxo Smith Kline's

Daiichi Sankyo Company

Intellia Therapeutics

Arcturus Therapeutics

Emmy Vaccine

CSPC

CanSino

Fosun Pharma

1 Market Overview

1.1 Product Overview and Scope of Messenger RNA Vaccines and Therapeutics

1.2 Global Messenger RNA Vaccines and Therapeutics Market Size and Forecast

1.3 China Messenger RNA Vaccines and Therapeutics Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Messenger RNA Vaccines and Therapeutics Share in Global Market, 2018-2029

1.4.2 Messenger RNA Vaccines and Therapeutics Market Size: China VS Global, 2018-2029

1.5 Messenger RNA Vaccines and Therapeutics Market Dynamics

1.5.1 Messenger RNA Vaccines and Therapeutics Market Drivers

1.5.2 Messenger RNA Vaccines and Therapeutics Market Restraints

1.5.3 Messenger RNA Vaccines and Therapeutics Industry Trends

1.5.4 Messenger RNA Vaccines and Therapeutics Industry Policy

2 Global Competitive Situation by Company

2.1 Global Messenger RNA Vaccines and Therapeutics Revenue by Company (2018-2023)

2.2 Global Messenger RNA Vaccines and Therapeutics Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Messenger RNA Vaccines and Therapeutics Concentration Ratio

2.4 Global Messenger RNA Vaccines and Therapeutics Mergers & Acquisitions, Expansion Plans

2.5 Global Messenger RNA Vaccines and Therapeutics Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Messenger RNA Vaccines and Therapeutics Revenue by Company (2018-2023)

3.2 China Messenger RNA Vaccines and Therapeutics Messenger RNA Vaccines and Therapeutics Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Messenger RNA Vaccines and Therapeutics, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Messenger RNA Vaccines and Therapeutics Industry Chain

4.2 Messenger RNA Vaccines and Therapeutics Upstream Analysis

4.3 Messenger RNA Vaccines and Therapeutics Midstream Analysis

4.4 Messenger RNA Vaccines and Therapeutics Downstream Analysis

5 Sights by Type

5.1 Messenger RNA Vaccines and Therapeutics Classification

5.1.1 Self-amplifying

5.1.2 Conventional Non-amplifying

5.2 By Type, Global Messenger RNA Vaccines and Therapeutics Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029

6 Sights by Application

6.1 Messenger RNA Vaccines and Therapeutics Segment by Application

6.1.1 Cancer

6.1.2 Infectious Diseases

6.1.3 Autoimmune Diseases

6.1.4 Others

6.2 By Application, Global Messenger RNA Vaccines and Therapeutics Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Messenger RNA Vaccines and Therapeutics Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Messenger RNA Vaccines and Therapeutics Market Size, 2018-2029

7.3 North America

7.3.1 North America Messenger RNA Vaccines and Therapeutics Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Messenger RNA Vaccines and Therapeutics Market Size Market Share

7.4 Europe

7.4.1 Europe Messenger RNA Vaccines and Therapeutics Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Messenger RNA Vaccines and Therapeutics Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Messenger RNA Vaccines and Therapeutics Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Messenger RNA Vaccines and Therapeutics Market Size Market Share

7.6 South America

7.6.1 South America Messenger RNA Vaccines and Therapeutics Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Messenger RNA Vaccines and Therapeutics Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Messenger RNA Vaccines and Therapeutics Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Messenger RNA Vaccines and Therapeutics Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Messenger RNA Vaccines and Therapeutics Market Size, 2018-2029

8.3.2 By Company, U.S. Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Messenger RNA Vaccines and Therapeutics Market Size, 2018-2029

8.4.2 By Company, Europe Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Messenger RNA Vaccines and Therapeutics Market Size, 2018-2029

8.5.2 By Company, China Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2023

8.5.3 By Type, China Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Messenger RNA Vaccines and Therapeutics Market Size, 2018-2029

8.6.2 By Company, Japan Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Messenger RNA Vaccines and Therapeutics Market Size, 2018-2029

8.7.2 By Company, South Korea Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Messenger RNA Vaccines and Therapeutics Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Messenger RNA Vaccines and Therapeutics Market Size, 2018-2029

8.9.2 By Company, India Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2023

8.9.3 By Type, India Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Messenger RNA Vaccines and Therapeutics Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 BioNTech

9.1.1 BioNTech Company Information, Head Office, Market Area and Industry Position

9.1.2 BioNTech Company Profile and Main Business

9.1.3 BioNTech Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

9.1.4 BioNTech Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

9.1.5 BioNTech Recent Developments

9.2 Moderna

9.2.1 Moderna Company Information, Head Office, Market Area and Industry Position

9.2.2 Moderna Company Profile and Main Business

9.2.3 Moderna Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

9.2.4 Moderna Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

9.2.5 Moderna Recent Developments

9.3 CureVac

9.3.1 CureVac Company Information, Head Office, Market Area and Industry Position

9.3.2 CureVac Company Profile and Main Business

9.3.3 CureVac Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

9.3.4 CureVac Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

9.3.5 CureVac Recent Developments

9.4 Pfizer

9.4.1 Pfizer Company Information, Head Office, Market Area and Industry Position

9.4.2 Pfizer Company Profile and Main Business

9.4.3 Pfizer Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

9.4.4 Pfizer Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

9.4.5 Pfizer Recent Developments

9.5 Glaxo Smith Kline's

9.5.1 Glaxo Smith Kline's Company Information, Head Office, Market Area and Industry Position

9.5.2 Glaxo Smith Kline's Company Profile and Main Business

9.5.3 Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

9.5.4 Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

9.5.5 Glaxo Smith Kline's Recent Developments

9.6 Daiichi Sankyo Company

9.6.1 Daiichi Sankyo Company Company Information, Head Office, Market Area and Industry Position

9.6.2 Daiichi Sankyo Company Company Profile and Main Business

9.6.3 Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

9.6.4 Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

9.6.5 Daiichi Sankyo Company Recent Developments

9.7 Intellia Therapeutics

9.7.1 Intellia Therapeutics Company Information, Head Office, Market Area and Industry Position

9.7.2 Intellia Therapeutics Company Profile and Main Business

9.7.3 Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

9.7.4 Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

9.7.5 Intellia Therapeutics Recent Developments

9.8 Arcturus Therapeutics

9.8.1 Arcturus Therapeutics Company Information, Head Office, Market Area and Industry Position

9.8.2 Arcturus Therapeutics Company Profile and Main Business

9.8.3 Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

9.8.4 Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

9.8.5 Arcturus Therapeutics Recent Developments

9.9 Emmy Vaccine

9.9.1 Emmy Vaccine Company Information, Head Office, Market Area and Industry Position

9.9.2 Emmy Vaccine Company Profile and Main Business

9.9.3 Emmy Vaccine Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

9.9.4 Emmy Vaccine Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

9.9.5 Emmy Vaccine Recent Developments

9.10 CSPC

9.10.1 CSPC Company Information, Head Office, Market Area and Industry Position

9.10.2 CSPC Company Profile and Main Business

9.10.3 CSPC Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

9.10.4 CSPC Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

9.10.5 CSPC Recent Developments

9.11 CanSino

9.11.1 CanSino Company Information, Head Office, Market Area and Industry Position

9.11.2 CanSino Company Profile and Main Business

9.11.3 CanSino Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

9.11.4 CanSino Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

9.11.5 CanSino Recent Developments

9.12 Fosun Pharma

9.12.1 Fosun Pharma Company Information, Head Office, Market Area and Industry Position

9.12.2 Fosun Pharma Company Profile and Main Business

9.12.3 Fosun Pharma Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

9.12.4 Fosun Pharma Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

9.12.5 Fosun Pharma Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Messenger RNA Vaccines and Therapeutics Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Messenger RNA Vaccines and Therapeutics Market Restraints

Table 3. Messenger RNA Vaccines and Therapeutics Market Trends

Table 4. Messenger RNA Vaccines and Therapeutics Industry Policy

Table 5. Global Messenger RNA Vaccines and Therapeutics Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Company (2018-2023)

Table 7. Global Messenger RNA Vaccines and Therapeutics Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Messenger RNA Vaccines and Therapeutics Mergers & Acquisitions, Expansion Plans

Table 9. Global Messenger RNA Vaccines and Therapeutics Manufacturers Product Type

Table 10. China Messenger RNA Vaccines and Therapeutics Revenue by Company (2018-2023) & (US$ million)

Table 11. China Messenger RNA Vaccines and Therapeutics Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Messenger RNA Vaccines and Therapeutics Upstream (Raw Materials)

Table 13. Global Messenger RNA Vaccines and Therapeutics Typical Customers

Table 14. Messenger RNA Vaccines and Therapeutics Typical Distributors

Table 15. By Type, Global Messenger RNA Vaccines and Therapeutics Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Messenger RNA Vaccines and Therapeutics Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Messenger RNA Vaccines and Therapeutics Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Messenger RNA Vaccines and Therapeutics Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2029

Table 22. BioNTech Company Information, Head Office, Market Area and Industry Position

Table 23. BioNTech Company Profile and Main Business

Table 24. BioNTech Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 25. BioNTech Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 26. BioNTech Recent Developments

Table 27. Moderna Company Information, Head Office, Market Area and Industry Position

Table 28. Moderna Company Profile and Main Business

Table 29. Moderna Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 30. Moderna Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 31. Moderna Recent Developments

Table 32. CureVac Company Information, Head Office, Market Area and Industry Position

Table 33. CureVac Company Profile and Main Business

Table 34. CureVac Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 35. CureVac Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 36. CureVac Recent Developments

Table 37. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 38. Pfizer Company Profile and Main Business

Table 39. Pfizer Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 40. Pfizer Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 41. Pfizer Recent Developments

Table 42. Glaxo Smith Kline's Company Information, Head Office, Market Area and Industry Position

Table 43. Glaxo Smith Kline's Company Profile and Main Business

Table 44. Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 45. Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 46. Glaxo Smith Kline's Recent Developments

Table 47. Daiichi Sankyo Company Company Information, Head Office, Market Area and Industry Position

Table 48. Daiichi Sankyo Company Company Profile and Main Business

Table 49. Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 50. Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 51. Daiichi Sankyo Company Recent Developments

Table 52. Intellia Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 53. Intellia Therapeutics Company Profile and Main Business

Table 54. Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 55. Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 56. Intellia Therapeutics Recent Developments

Table 57. Arcturus Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 58. Arcturus Therapeutics Company Profile and Main Business

Table 59. Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 60. Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 61. Arcturus Therapeutics Recent Developments

Table 62. Emmy Vaccine Company Information, Head Office, Market Area and Industry Position

Table 63. Emmy Vaccine Company Profile and Main Business

Table 64. Emmy Vaccine Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 65. Emmy Vaccine Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 66. Emmy Vaccine Recent Developments

Table 67. CSPC Company Information, Head Office, Market Area and Industry Position

Table 68. CSPC Company Profile and Main Business

Table 69. CSPC Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 70. CSPC Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 71. CSPC Recent Developments

Table 72. CanSino Company Information, Head Office, Market Area and Industry Position

Table 73. CanSino Company Profile and Main Business

Table 74. CanSino Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 75. CanSino Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 76. CanSino Recent Developments

Table 77. Fosun Pharma Company Information, Head Office, Market Area and Industry Position

Table 78. Fosun Pharma Company Profile and Main Business

Table 79. Fosun Pharma Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 80. Fosun Pharma Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 81. Fosun Pharma Recent Developments

List of Figure

Figure 1. Messenger RNA Vaccines and Therapeutics Picture

Figure 2. Global Messenger RNA Vaccines and Therapeutics Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Messenger RNA Vaccines and Therapeutics Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Messenger RNA Vaccines and Therapeutics Market Share of Global

Figure 5. Global Messenger RNA Vaccines and Therapeutics Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Messenger RNA Vaccines and Therapeutics Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Messenger RNA Vaccines and Therapeutics Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Messenger RNA Vaccines and Therapeutics Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Messenger RNA Vaccines and Therapeutics Industry Chain

Figure 10. Self-amplifying

Figure 11. Conventional Non-amplifying

Figure 12. By Type, Global Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, US$ Million

Figure 13. By Type, Global Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2029

Figure 14. Cancer

Figure 15. Infectious Diseases

Figure 16. Autoimmune Diseases

Figure 17. Others

Figure 18. By Application, Global Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, US$ Million

Figure 19. By Application, Global Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2029

Figure 20. By Region, Global Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2029

Figure 21. North America Messenger RNA Vaccines and Therapeutics Revenue & Forecasts, 2018-2029, US$ Million

Figure 22. By Country, North America Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2023

Figure 23. Europe Messenger RNA Vaccines and Therapeutics Revenue & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, Europe Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2023

Figure 25. Asia Pacific Messenger RNA Vaccines and Therapeutics Revenue & Forecasts, 2018-2029, US$ Million

Figure 26. By Country/Region, Asia Pacific Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2023

Figure 27. South America Messenger RNA Vaccines and Therapeutics Revenue & Forecasts, 2018-2029, US$ Million

Figure 28. By Country, South America Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2023

Figure 29. Middle East & Africa Messenger RNA Vaccines and Therapeutics Revenue & Forecasts, 2018-2029, US$ Million

Figure 30. U.S. Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, (US$ Million)

Figure 31. By Company, U.S. Messenger RNA Vaccines and Therapeutics Market Share, 2018-2023

Figure 32. By Type, U.S. Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 33. By Application, U.S. Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 34. Europe Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, (US$ Million)

Figure 35. By Company, Europe Messenger RNA Vaccines and Therapeutics Market Share, 2018-2023

Figure 36. By Type, Europe Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 37. By Application, Europe Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 38. China Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, (US$ Million)

Figure 39. By Company, China Messenger RNA Vaccines and Therapeutics Market Share, 2018-2023

Figure 40. By Type, China Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 41. By Application, China Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 42. Japan Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, (US$ Million)

Figure 43. By Company, Japan Messenger RNA Vaccines and Therapeutics Market Share, 2018-2023

Figure 44. By Type, Japan Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 45. By Application, Japan Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 46. South Korea Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, (US$ Million)

Figure 47. By Company, South Korea Messenger RNA Vaccines and Therapeutics Market Share, 2018-2023

Figure 48. By Type, South Korea Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 49. By Application, South Korea Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 50. Southeast Asia Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, (US$ Million)

Figure 51. By Company, Southeast Asia Messenger RNA Vaccines and Therapeutics Market Share, 2018-2023

Figure 52. By Type, Southeast Asia Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 53. By Application, Southeast Asia Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 54. India Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, (US$ Million)

Figure 55. By Company, India Messenger RNA Vaccines and Therapeutics Market Share, 2018-2023

Figure 56. By Type, India Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 57. By Application, India Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 58. Middle East & Asia Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, (US$ Million)

Figure 59. By Company, Middle East & Asia Messenger RNA Vaccines and Therapeutics Market Share, 2018-2023

Figure 60. By Type, Middle East & Asia Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 61. By Application, Middle East & Asia Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 62. Research Methodology

Figure 63. Breakdown of Primary Interviews

Figure 64. Bottom-up Approaches

Figure 65. Top-down Approaches